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In at least one third of acute ischemic strokes, investigative protocols fail to establish the exact etiology.1,2 Etiologic 
workup in such cases of cryptogenic stroke, or stroke of un-
known origin, is complicated by the varied emphasis of cli-
nicians on establishing underlying cause because of the lack 
of evidence-based secondary prevention strategies3–5 and var-
iable availability of different investigative techniques. Recent 
efforts to facilitate trials of secondary prevention strategies 
have resulted in the development of the embolic strokes of 
undetermined source construct (ESUS), which describes the 
subgroup of nonlacunar cryptogenic ischemic strokes in which 
embolism is considered the likely mechanism.6 Two trials of 
non–vitamin K antagonist oral anticoagulants in ESUS popu-
lations however failed to show a reduction in recurrent stroke 
when compared with aspirin,7,8 with one trial showing pos-
sible harm with an excess of bleeding.7 This may be because 
Background and Purpose—Identifying the etiology of acute ischemic stroke is essential for effective secondary prevention. 
However, in at least one third of ischemic strokes, existing investigative protocols fail to determine the underlying cause. 
Establishing etiology is complicated by variation in clinical practice, often reflecting preferences of treating clinicians and 
variable availability of investigative techniques. In this review, we systematically assess the extent to which there exists 
consensus, disagreement, and gaps in clinical practice recommendations on etiologic workup in acute ischemic stroke.
Methods—We identified clinical practice guidelines/consensus statements through searches of 4 electronic databases and 
hand-searching of websites/reference lists. Two reviewers independently assessed reports for eligibility. We extracted 
data on report characteristics and recommendations relating to etiologic workup in acute ischemic stroke and in cases of 
cryptogenic stroke. Quality was assessed using the AGREE II tool (Appraisal of Guidelines for Research & Evaluation). 
Recommendations were synthesized according to a published algorithm for diagnostic evaluation in cryptogenic stroke.
Results—We retrieved 16 clinical practice guidelines and 7 consensus statements addressing acute stroke management 
(n=12), atrial fibrillation (n=5), imaging (n=5), and secondary prevention (n=1). Five reports were of overall high quality. 
For all patients, guidelines recommended routine brain imaging, noninvasive vascular imaging, a 12-lead ECG, and routine 
blood tests/laboratory investigations. Additionally, ECG monitoring (>24 hours) was recommended for patients with 
suspected embolic stroke and echocardiography for patients with suspected cardiac source. Three reports recommended 
investigations for rarer causes of stroke. None of the reports provided guidance on the extent of investigation needed 
before classifying a stroke as cryptogenic.
Conclusions—While consensus exists surrounding standard etiologic workup, there is little agreement on more advanced 
investigations for rarer causes of acute ischemic stroke. This gap in guidance, and in the underpinning evidence, 
demonstrates missed opportunities to better understand and protect against ongoing stroke risk.
Registration—URL: https://www.crd.york.ac.uk/PROSPERO/; Unique identifier: CRD42019127822. 
  (Stroke. 2020;51:1419-1427. DOI: 10.1161/STROKEAHA.119.027123.)
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of unidentified heterogeneity even within the ESUS subgroup, 
resulting in the inclusion of patients who were unlikely to ben-
efit from anticoagulation as a secondary prevention strategy.9 
These trials have demonstrated that one size does not fit all 
and further highlighted the importance of systematic and ev-
idence-based investigation of cryptogenic stroke to facilitate 
the development and implementation of personalized sec-
ondary prevention strategies. In this review, we use Saver’s10 
algorithm for etiologic workup in cryptogenic stroke to sys-
tematically assess the extent to which there exists consensus, 
disagreement, and gaps in clinical practice recommendations 
on etiologic workup in acute ischemic stroke. The review 
findings highlight priorities for future research to inform more 
standardized approaches to evaluating cryptogenic stroke.
Methods
The review was designed in accordance with the Preferred Reporting 
Items for Systematic Review and Meta-Analysis guidance. A Preferred 
Reporting Items for Systematic Review and Meta-Analysis checklist 
is provided in Appendix A in the Data Supplement. The protocol was 
prospectively registered on PROSPERO: CRD42019127822.
Eligibility Criteria
Clinical practice guidelines (CPGs) were included if they (1) were 
endorsed by a national and/or international organization (eg, govern-
mental, charitable, professional practice), (2) included recommen-
dations about etiologic workup in acute ischemic stroke, (3) were 
published from January 2009 onwards (to ensure only the most up-
to-date guidelines were included), and (4) were available in English. 
During our searches, we also identified scientific statements and con-
sensus documents. Although these reports used less robust methods 
to search for and synthesize the underpinning evidence, the content 
was sufficiently relevant to the objectives of the review to merit inclu-
sion. For transparency, recommendations from these publications are 
presented separately throughout.
Search Strategy and Guideline Selection
We searched 4 electronic databases (MEDLINE, Health Management 
Information Consortium (HMIC), Embase, and CINAHL) from their 
inception to the 4th of March 2019 using a combination of Medical 
Subject Headings and keywords. As CPGs are often not indexed by 
electronic databases, we also systematically searched for guidelines 
on relevant websites including, but not limited to, the Guidelines 
International Network (www.g-i-n.net); The American Academy of 
Neurology (www.aan.com/); The World Stroke Organisation (www.
world-stroke.org); and Open Grey (www.opengrey.eu/). Additionally, 
we reviewed the reference lists of included CPGs to identify relevant 
guidelines. The final list of CPGs/consensus statements was reviewed 
by all authors to confirm that no relevant documents, of which the 
team were already aware, had been omitted. The complete search 
strategy is provided in Appendix B in the Data Supplement. Two 
reviewers (Drs McMahon and Bangee) independently screened all 
retrieved citations for eligibility. Full texts of potentially relevant cita-
tions were obtained and independently assessed by both reviewers. 
Uncertainty was resolved through discussions with the review group.
Data Collection and Quality Appraisal
A bespoke data extraction form was piloted before being finalized. 
For each guideline, one reviewer extracted all relevant information 
using this form, which was then fully checked by a second reviewer 
for completeness and accuracy. We extracted the following informa-
tion: authors; organization; year of publication; country/region; de-
velopment approach, evidence-assessment scales, and approach to 
producing recommendations; funding and disclosures; any content 
relating to the level of etiologic workup required in acute ischemic 
stroke. Relevant supplementary material cited in the guidelines was 
also retrieved and used to inform data extraction and quality appraisal.
The AGREE II tool (Appraisal of Guidelines for Research and 
Evaluation II11) was used to assess and illustrate the quality of the 
included publications. This tool includes 6 quality domains: scope 
and purpose; stakeholder involvement; rigor of development; 
clarity and presentation; applicability; and editorial independence. 
Each guideline was independently assessed by 4 appraisers from 
the review team (Dr McMahon, Dr Bangee, Dr Bray, Dr Gibson, 
R.F. Georgiou, Dr Benedetto, Dr Lane) and a quality score calcu-
lated for each domain as per the AGREE II formula.12 In line with 
similar reviews, we assessed agreement for each domain item and 
collectively reviewed items where appraisers scores were >1.5 SD 
from the mean item score.13 A domain was considered to be ade-
quately addressed if scoring was ≥60%.13–16 The data extraction 
and quality appraisal forms are provided in Appendix C in the 
Data Supplement.
Synthesis
All recommendations describing etiologic workup in acute ischemic 
stroke were collated in a spreadsheet and synthesized according 
to Saver’s10 algorithm for etiologic workup in cryptogenic stroke. 
Additional informal commentary was similarly collated in a spread-
sheet and content analysis performed. These stages of refining and 
synthesizing the data were regularly discussed with the review team, 
particularly practising clinicians, to determine the consistency and 
appropriateness of the process and decision-making.
Results
The electronic search strategy retrieved a total of 8442 cita-
tions. After the removal of duplicates and pre-2009 publica-
tions, 4566 were screened on title and abstract. We assessed 
114 full texts for eligibility, of which 23 were included in the 
review (Figure). A full list of excluded records with reasons is 
provided in Appendix D in the Data Supplement.
Characteristics and Quality of the 
Included Guidelines/Statements
An overview of the included guidelines/statements is provided 
in Table 1.
There were 16 CPGs17–32 and 7 organizational statements 
or consensus documents.33–39 Most publications came from 
American (n=5),18,23,35,38,39 European (n=3),25,33,36,37 Canadian 
(n=3),19,20,27 and British organizations (n=3).17,24,28 Topics in-
cluded acute stroke management (n=12),17–19,22,24,26,29–32,34,38 
atrial fibrillation and tachyarrhythmias (n=5),21,25,27,28,33 im-
aging in acute stroke (n=5),23,35–37,39 and secondary prevention 
(n=1).20 Just under half (n=11) were published from 2016 
onwards.17–26,33 Two guidelines disclosed industry support in 
the production of the guidelines.30,31
The mean quality appraisal scores of 4 reviewers for 
each domain of the AGREE II are shown in Table 2, where 
green indicates domains which were adequately addressed 
(ie, ≥60%). For completeness, we also appraised the in-
cluded consensus statements, which, as expected, scored less 
favorably than the CPGs. Almost all documents adequately 
addressed Domain 4 (clarity of presentation), which was the 
highest scoring domain followed by Domain 1 (scope and pur-
pose). Applicability (Domain 5) scored most poorly, with this 
domain also noted to have the poorest agreement across raters. 
Five reports were of high quality overall, scoring ≥60% across 
all 5 domains.17,19,20,22,28
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Establishing Stroke Etiology
Of the guidelines/statements specific to acute stroke man-
agement (n=12), 7 explicitly highlighted the importance of 
establishing stroke etiology19,22,24,30–32,34 (Table I in the Data 
Supplement). Two made recommendations on additional 
investigations to be performed for ESUS patients,19,22 with 
a further 4 reports providing recommendations on tests that 
should be considered in selected patients where cause has not 
been established through standard workup.24,30,31,34
Reflective of Saver’s algorithm,10 we organized recom-
mendations into 6 categories of investigation: (1) brain im-
aging, (2) vascular imaging, (3) cardiac rhythm, (4) cardiac 
structure, (5) laboratory, and (6) other investigations (Table 3). 
Full details of all guideline recommendations with respect to 
these 6 categories of investigations are provided in Tables II 
through VII in the Data Supplement, while a summary of the 
recommendations for diagnostic workup in acute ischemic 
stroke can be found in Table 3. For reference purposes, the 
Figure. PRISMA flow diagram. HMIC indicates Health Management Information Consortium.
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Table 1. Characteristics of Included Guidelines and Consensus Statements
Country/Region Organization Lead Author (Year) Title Development Approach
Clinical practice guidelines
  United Kingdom National Institute for Health and Care 
Excellence
National Institute  
for Health and Care  
Excellence (2019)17
Stroke and transient ischemic 
attack in over 16s: diagnosis and 
initial management (NG128)
Systematic search
GRADE framework
  United States American Heart Association/American 
Stroke Association
Powers et al 
(2018)18
2018 Guidelines for the Early 
Management of Patients 
With Acute Ischemic Stroke: 
A Guideline for Healthcare 
Professionals From the American 
Heart Association/American 
Stroke Association
Systematic search
  Canada Acute Stroke Management Best Practice 
Writing Group, and the Canadian Stroke 
Best Practices and Quality Advisory 
Committees; in collaboration with the 
Canadian Stroke Consortium and the 
Canadian Association of Emergency 
Physicians
Boulanger et al 
(2018)19
Canadian Stroke Best Practice 
Recommendations for Acute 
Stroke Management: Prehospital, 
Emergency Department, and 
Acute Inpatient Stroke Care, 6th 
Edition, Update 2018
Systematic search
Framework adapted from the Practice 
Guideline Evaluation and Adaptation 
Cycle
  Canada Heart and Stroke Foundation Canadian 
Stroke Best Practice Committees
Wein et al (2018)20 Canadian Stroke Best Practice 
Recommendations: Secondary 
Prevention of Stroke, Sixth Edition  
Practice Guidelines, Update 2017
Systematic search
Framework adapted from the Practice 
Guideline Evaluation and Adaptation 
Cycle
  Korea Korean Heart Rhythm Society (KHRS) 
Committee
Joung et al (2018)21 2018 Korean Guideline of Atrial 
Fibrillation Management
Systematic search
Based on recent data of the Korean 
population and the recent guidelines 
of the European Society of Cardiology, 
European Association for Cardio-
Thoracic Surgery, American Heart 
Association, and Asia Pacific Heart 
Rhythm Society
  Australia Stroke Foundation/Australian 
Department of Health
Stroke Foundation 
(2017)22
Clinical Guidelines for Stroke 
Management 2017
Systematic search
GRADE framework
  United States American Society of Echocardiography 
(ASE)
Saric et al (2016)23 Guidelines for the Use of 
Echocardiography in the 
Evaluation of a Cardiac Source of 
Embolism
Based on an extensive literature review 
including all other relevant guidelines 
from the ASE and other national and 
international medical societies
  United Kingdom Royal College of Physicians Intercollegiate 
Stroke Working 
Party (2016)24
National Clinical Guideline for 
Stroke
Systematic search
  Europe European Society of Cardiology Kirchhof et al 
(2016)25
2016 ESC Guidelines for the 
Management of Atrial Fibrillation 
Developed in Collaboration With 
EACTS
Based on a comprehensive review 
of the published evidence for 
management (including diagnosis, 
treatment, prevention and 
rehabilitation) of a given condition
  Qatar Ministry of Public Health Ministry of Public 
Health (2016)26
Clinical Guidelines for the State 
of Qatar: The Diagnosis and 
Management of Stroke and 
Transient Ischemic Attack
Systematic search
  Canada Canadian Cardiovascular Society Verma et al (2014)27 2014 Focused Update of the 
Canadian Cardiovascular Society 
Guidelines for the Management 
of Atrial Fibrillation
Based on a thorough consideration 
of medical literature and the best 
available evidence and clinical 
experience
  United Kingdom National Institute for Health and Care 
Excellence
National Institute  
for Health and Care  
Excellence (2014)28
Atrial fibrillation: management 
(CG180)
Systematic search
GRADE framework
(Continued )
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  Brazil Brazilian Academy of Neurology Oliveira-Filho et al 
(2012)29
Guidelines for Acute Ischemic 
Stroke Treatment—Part I
Members from Brazilian Stroke Society 
participated in web-based discussion 
forum with predefined themes, 
followed by a formal onsite meeting
  Malaysia Ministry of Health Malaysia, Academy 
of Medicine Malaysia, Malaysian 
Society of Neurosciences
Malaysian Society 
of Neurosciences 
(2012)30
Management of Ischaemic Stroke 
(2nd Edition)
A standard methodology based on a 
systematic review of current evidence 
was used to look at the literature
  South Africa South African Stroke Society (SASS) 
and the SASS Writing Committee
Bryer et al (2010)31 South African Guideline for 
Management of Ischaemic Stroke 
and Transient Ischaemic Attack 
2010: A Guideline From the South 
African Stroke Society (SASS) and 
the SASS Writing Committee
Authors were nominated by consensus 
to write chapters of the Guideline. 
Submissions were first discussed in a 
meeting of the Stroke Guideline Writing 
Committee
  Singapore Ministry of Health Ministry of 
Health. Stroke 
and Transient 
Ischaemic Attacks 
Assessment, 
Investigation, 
Immediate 
Management 
and Secondary 
Prevention (2009)32
Stroke and Transient Ischaemic 
Attacks. Assessment, 
Investigation, Immediate 
Management and Secondary 
Prevention
Based on the Scottish Intercollegiate 
Guidelines Network’s Clinical Practice 
Guidelines on the Management of 
Patients with Stroke. These guidelines 
were reviewed and modified to meet 
local needs
Scientific statements and consensus documents
  Europe European Heart Rhythm Association Gorenek et al 
(2017)33
Device-detected subclinical atrial 
tachyarrhythmias: definition, 
implications and management—
an European Heart Rhythm 
Association (EHRA) consensus 
document, endorsed by Heart 
Rhythm Society (HRS), Asia Pacific 
Heart Rhythm Society (APHRS) 
and Sociedad Latinoamericana 
de Estimulacióín Cardíaca y 
Electrofisiología (SOLEACE)
This is evidence-based, and derived 
primarily from published data
  India Indian Stroke Association Prasad et al 
(2014)34
Recommendations for the Early 
Management of Acute Ischemic 
Stroke: A Consensus Statement 
for Healthcare Professionals from 
the Indian Stroke Association
Systematic literature reviews, clinical 
and epidemiology study publications, 
and clinical and public health 
guidelines were used to summarize 
the existing evidence and indicate 
gaps in the current knowledge and, 
when appropriate, formulate the 
recommendations
  United States American Society of Neuroradiology Wintermark et al 
(2013)35
Imaging Recommendations 
for Acute Stroke and Transient 
Ischemic Attack Patients: A 
Joint Statement by the American 
Society of Neuroradiology, 
the American College of 
Radiology and the Society of 
NeuroInterventional Surgery
Based on a review of the evidence in 
the literature on the utility of various 
imaging techniques in acute stroke  
and TIA patients
  Europe European Federation of Neurological 
Societies
Irimia et al (2011)36 Use of imaging in 
cerebrovascular disease
A comprehensive literature review 
using the MEDLINE database search 
the period 1965–2009. Relevant 
literature in English, including existing 
guidelines, meta-analyses, systematic 
reviews, randomized controlled trials, 
and observational studies have been 
critically assessed
Table 1. Continued
Country/Region Organization Lead Author (Year) Title Development Approach
(Continued )
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different evidence assessment scales and class of recommen-
dations used in the included guidelines can also be found in 
Appendix E in the Data Supplement. For all patients with 
suspected acute stroke, guidelines recommend that they rou-
tinely undergo brain imaging, noninvasive vascular imaging, 
a 12-lead ECG, and routine blood tests/laboratory investiga-
tions. Recommendations on additional investigations included 
ECG monitoring for >24 hours for patients being investigated 
for embolic stroke (extended if atrial fibrillation is not detected 
but a cardioembolic source is suspected) and echocardiog-
raphy for patients where etiology has not been established 
but a cardiac source is suspected. Three guidelines provided 
recommendations of further investigations for more unusual 
causes of stroke. These investigations included serology for 
Chagas disease and syphilis29 and, in younger people spe-
cifically, evaluation of autoimmune diseases, prothrombotic 
states (eg, antiphospholipid syndrome),24,29 Fabry disease,24 
and thrombophilia.26,29
While cryptogenic stroke was often discussed in the context 
of established classification systems (notably TOAST [Trial of 
ORG 10172 in Acute Stroke Treatment]21,23,25–27,37), none of the 
included guidelines/statements went beyond the TOAST cat-
egories to specifically identify when a stroke should be clas-
sified as cryptogenic (Tables VIII in the Data Supplement). 
More recently published guidelines using the ESUS construct 
included recommendations on prolonged cardiac monitoring, 
but lacked guidance on investigating other stroke mechanisms, 
and the extent to which investigations should be undertaken to 
establish stroke cause.
Discussion
We have presented a systematic assessment of recommenda-
tions from international CPGs and consensus statements de-
tailing etiologic workup in acute ischemic stroke. The review 
demonstrates that clear consensus exists on investigations 
which should be routinely performed for all acute ischemic 
stroke patients (standard evaluation10), but highlights the lack 
of consistency and detail on additional investigations for 
patients in whom a cause is not identified through standard 
evaluation. While recently published high-quality guidelines 
using the ESUS construct included recommendations for ad-
vanced evaluation focusing on prolonged ECG monitoring 
(ie, >24 hours), they do not yet provide guidance on the op-
timum or desired duration of monitoring. Indeed, the most 
recent update of the American Heart Association/American 
Stroke Association Guidelines for the Early Management of 
Acute Ischemic Stroke, published following the completion 
of this review, further reiterates that the effectiveness of pro-
longed cardiac monitoring for the purposes of guiding sec-
ondary prevention remains uncertain.40 Additionally, as ESUS 
represents only a subgroup of cryptogenic stroke, guidance 
is still lacking for those patients where the stroke mechanism 
is not embolic. Indeed, consideration of more unusual causes 
of stroke was limited to just 3 reports, all of which were pub-
lished in 2016 or earlier.24,26,29 It was therefore not possible 
to identify a standardized evaluation approach from current 
guidelines, suggesting that practice variability in investigating 
cryptogenic stroke is inevitable. Practice variability is likely 
to be further compounded by the limited attention paid to the 
applicability of recommendations across included reports, a 
limitation of CPGs often highlighted in published reviews.13,14
This review has highlighted the need for well-designed 
primary research to identify an optimal pathway to expedite 
the identification of rare and very rare stroke etiologies in a 
timely and cost-effective manner. A significant challenge to 
further clinically based research is, however, the rarity of 
these causes. Additionally, as treating healthcare profession-
als are deeply engaged in dealing with the consequences of the 
current stroke, advanced etiologic workup often takes a back 
seat. While the TOAST classification acts as a useful start-
ing point, it is evident that further research is needed to un-
derpin and guide investigation in clinical practice. However, 
because of the lack of individualized secondary prevention 
strategies, such research should include economic analysis 
to compare the costs, risks, and benefits of less or more ex-
haustive approaches, while also exploring variation in stroke 
  Europe European Association of 
Echocardiography (EAE)
Pepi et al (2010)37 Recommendations for 
Echocardiography Use in the 
Diagnosis and Management of 
Cardiac Sources of Embolism
Based on a literature review conducted 
using Medline (PubMed) for peer-
reviewed publications and focuses on 
the studies published mainly in the 
last 10 y
  United States American Heart Association Summers et al 
(2009)38
Comprehensive Overview of 
Nursing and Interdisciplinary 
Care of the Acute Ischemic 
Stroke Patient: A Scientific 
Statement From the American 
Heart Association
No systematic search reported
  United States American Heart Association Latchaw et al 
(2009)39
Recommendations for Imaging 
of Acute Ischemic Stroke: A 
Scientific Statement From the 
American Heart Association
The review has been confined to 
literature in English and includes all 
relevant articles but focuses on the 
literature from 2000–2006, with some 
more recent
GRADE indicates Grading of Recommendations Assessment, Development and Evaluation; EACTS, European Association for Cardio-Thoracic Surgery; and TIA, 
transient ischemic attack.
Table 1. Continued
Country/Region Organization Lead Author (Year) Title Development Approach
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subtype by race and ethnicity, along with genetic differences. 
Importantly, the perspectives of stroke survivors and family 
members are paramount and should guide future research and 
implementation, enabling a personalized approach for each 
individual based not only on their clinical presentation but 
also on their values, needs, and preferences.
Conclusions
Current CPGs on the etiologic workup of acute ischemic 
stroke are of variable quality but largely reach consensus about 
appropriate standard investigations. There is, however, little 
agreement and a lack of underpinning evidence for more ad-
vanced or specialized investigations for rarer causes of stroke. 
This lack of evidence and consensus, along with poor applica-
bility of many of the existing guidelines, is likely to contribute 
to variability of access to investigations, inappropriate use of 
costly and specialized resources and skills, along with delays 
or lack of diagnosis of etiologies. Unless addressed, this gap 
in knowledge will continue to result in missed opportunities 
to identify and implement necessary secondary prevention 
measures and provide high-quality clinical and psychological 
advice and support to stroke survivors and their families in 
relation to ongoing stroke risk.
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Table 2. AGREE II Appraisal of Included Studies
Guideline
Domain 1: 
Scope and 
Purpose
Domain 2: 
Stakeholder 
Involvement
Domain 3: 
Rigor of 
Development
Domain 4: 
Clarity of 
Presentation
Domain 5: 
Applicability
Domain 6: 
Editorial 
Independence
Clinical practice guidelines
  National Institute for Health and Care Excellence (2019)17 88 99 90 86 78 77
  Powers et al (2018)18 88 50 74 99 25 52
  Boulanger et al (2018)19 74 94 70 90 74 92
  Wein et al (2018)20 60 90 71 69 71 85
  Joung et al (2018)21 56 11 32 81 9 56
  Stroke Foundation/Australian Department of Health (2017)22 100 94 91 93 81 100
  Saric et al (2016)23 71 15 24 63 9 38
  Intercollegiate Stroke Working Party (2016)24 86 67 60 88 57 94
  Kirchhof et al (2016)25 58 33 67 89 33 65
  Ministry of Public Health (2016) [Qatar]26 65 49 31 81 8 73
  Verma et al (2014)27 50 42 10 82 35 40
  National Institute for Health and Care Excellence (2014)28 88 94 91 89 90 79
  Oliveira-Filho et al (2012)29 43 26 9 57 7 17
  Ministry of Health Malaysia, Academy of Medicine 
Malaysia, Malaysian Society of Neurosciences (2012)30
94 56 41 89 61 23
  Bryer et al (2010)31 50 47 28 83 53 73
  Ministry of Health (2009) [Singapore]32 60 69 20 83 20 4
Scientific statements and consensus documents
  Gorenek et al (2017)33 65 32 31 85 15 52
  Prasad et al (2014)34 72 32 9 75 23 8
  Wintermark et al (2013)35 54 11 13 54 32 6
  Irimia et al (2011)36 75 44 38 76 13 31
  Pepi et al (2010)37 65 4 30 79 9 21
  Summers et al (2009)38 50 32 20 85 13 46
  Latchaw et al (2009)39 60 8 38 75 13 46
Domain adequately addressed if ≥60%. AGREE II indicates Appraisal of Guidelines for Research and Evaluation II.
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